New tool is major milestone against lethal condition, TAU researchers say
Antimicrobial resistance is one of the biggest threats to global health, affecting anyone, at any age, in any country, according to the World Health Organization. Currently, 700,000 deaths each year are attributed to antimicrobial resistance, a figure which could increase to 10 million a year by 2050 save further intervention.
New breakthrough technology from Tel Aviv University facilitates DNA delivery into drug-resistant bacterial pathogens, enabling their manipulation. The research expands the range of bacteriophages, which are the primary tool for introducing DNA into pathogenic bacteria to neutralize their lethal activity. A single type of bacteriophage can be adapted to a wide range of bacteria, an innovation which will likely accelerate the development of potential drugs based on this principle.
Prof. Udi Qimron of the Department of Clinical Microbiology and Immunology at TAU’s Sackler Faculty of Medicine led the research team, which also included Dr. Ido Yosef, Dr. Moran Goren, Rea Globus and Shahar Molshanski, all of Prof. Qimron’s lab. The study was recently published in Molecular Cell and featured on its cover.
For the research, the team genetically engineered bacteriophages to contain the desired DNA rather than their own genome. They also designed combinations of nanoparticles from different bacteriophages, resulting in hybrids that are able to recognize new bacteria, including pathogenic bacteria. The researchers further used directed evolution to select hybrid particles able to transfer DNA with optimal efficiency.
“DNA manipulation of pathogens includes sensitization to antibiotics, killing of pathogens, disabling pathogens’ virulence factors and more,” Prof. Qimron said. “We’ve developed a technology that significantly expands DNA delivery into bacterial pathogens. This may indeed be a milestone, because it opens up many opportunities for DNA manipulations of bacteria that were impossible to accomplish before.
“This could pave the way to changing the human microbiome — the combined genetic material of the microorganisms in humans — by replacing virulent bacteria with a-virulent bacteria and replacing antibiotic-resistant bacteria with antibiotic-sensitive bacteria, as well as changing environmental pathogens,” Prof. Qimron continued.
“We have applied for a patent on this technology and are developing products that would use this technology to deliver DNA into bacterial pathogens, rendering them a-virulent and sensitive to antibiotics,” Prof. Qimron said.
The Latest on: Antimicrobial resistance
- CDC launches new plan to tackle antibiotic-resistant infectionson October 9, 2020 at 10:19 am
U.S. Centers for Disease Control and Prevention officials announced Friday what they describe as a "national action plan" to fight antibiotic-resistant infections.
- Natural eye drop could help fight antibiotic-resistant gonococcal blindness in infantson October 9, 2020 at 6:25 am
A natural treatment for an antibiotic-resistant bacterial infection that causes blindness in infants can be effectively administered through a simple eye drop without causing irritation, Kingston ...
- Threat of antibiotic resistance looms largeon October 8, 2020 at 8:16 pm
While COVID-19 has garnered significant attention from the public and media, antibiotic resistance is a slow-moving threat to global health that is often overlooked even though the World Health ...
- Virginia Tech to build a cyberinfrastructure for wastewater antibiotic-resistant gene monitoringon October 8, 2020 at 7:59 pm
Antibiotic resistance is a grand challenge of the 21st century. According to the U.S. Centers for Disease Control and Prevention, antibiotic resistance rates are increasing globally, with an estimated ...
- Team taps into wastewater antibiotic-resistant gene monitoringon October 8, 2020 at 8:18 am
With a $1.3 million grant from the National Science Foundation, researchers will build a cyberinfrastructure system, known as CI-WARS, for monitoring wastewater treatment plants for possible ...
- Global Antibiotic Resistance Markets, 2020-2024: New Technologies and New Drugs are Under Development to Capture this Growing Marketon October 7, 2020 at 6:30 am
Antimicrobial Resistance is creating new kinds of infections and superbugs that are resistant to current antibiotic medicines. New technologies (and new drugs) are under development to capture this ...
- Pharmaceutical strategy must address antimicrobial resistance, MEPs urgeon October 6, 2020 at 2:49 am
Thirty European Parliament lawmakers have written to Health Commissioner Stella Kyriakides calling for the EU pharmaceutical strategy to integrate the development of, and access to, affordable and ...
- Bennet, Young Introduce Legislation to Fight Antimicrobial Resistanceon October 2, 2020 at 10:10 am
Bennet, Young Introduce Legislation to Fight Antimicrobial Resistance. Bipartisan Bill Would Encourage Development of Innovative Antibiotics to Treat Resistant Infections and Impr ...
- Global Antibiotic Resistance Markets Report 2020: Top Selling Drugs 2011-2015 & Updated Forecast to 2024 - ResearchAndMarkets.comon October 2, 2020 at 3:29 am
Therapeutics By Pathogen and Therapy Type 2020 To 2024" report has been added to ResearchAndMarkets.com's offering.
- Global Antibiotic Resistance Markets Report 2020: Therapeutic Analysis 2017-2019 & 2020-2023 by Pathogen and Therapy Type with Situation Analysis - ResearchAndMarkets.comon October 2, 2020 at 1:32 am
The "Antibiotic Resistance Markets - Therapeutics By Pathogen and Therapy Type With Situation Analysis, Executive & Investor Guides & Customization 2019 to 2023" report has been added to ...
via Google News and Bing News